Finally, PEITC is capable of suppressing multiple oncogenic signaling pathways that are hyperactive in human prostate cancer [18], including nuclear factor-κB (NF-κB) [19], Akt [20], signal transducer and activator of transcription 3 (STAT3) [21], and androgen receptor [22]. Here, STAT3 is linked to prostate cancer.